Suppr超能文献

糖基磷脂酰肌醇(GPI)锚定淋巴细胞蛋白的内化作用。II. GPI锚定分子和跨膜分子通过不同途径内化。

Internalization of glycosyl-phosphatidylinositol (GPI)-anchored lymphocyte proteins. II. GPI-anchored and transmembrane molecules internalize through distinct pathways.

作者信息

Bamezai A, Goldmacher V S, Rock K L

机构信息

Harvard Medical School, Department of Pathology, Boston, MA.

出版信息

Eur J Immunol. 1992 Jan;22(1):15-21. doi: 10.1002/eji.1830220104.

Abstract

Ly-6A.2 (T cell-activating protein, TAP) and Thy-1 are glycosyl-phosphatidyl-inositol (GPI)-anchored proteins expressed on the surface of murine T lymphocytes. We have found that Ly-6A.2 (TAP) and Thy-1 are internalized by T cells. In the present study we have investigated whether these GPI-anchored proteins enter cells by endocytosis through coated pits. Two lines of evidence argue against the involvement of coated pits in the internalization of Ly-6A.2 (TAP) and Thy-1. First, drugs that effectively blocked the endocytosis of transferrin receptor and H-2 class I molecules, (which are known to be internalized via coated pits) did not inhibit the internalization of the GPI-anchored proteins. Second, in ultrastructural analyses, Ly-6A2 (TAP) and Thy-1, in contrast to the transferrin receptor, were rarely found in coated pits or vesicles. These observations suggest that the GPI-anchored proteins on T lymphocytes are internalized by a distinct pathway that does not involve endocytosis through coated pits.

摘要

Ly-6A.2(T细胞激活蛋白,TAP)和Thy-1是糖基磷脂酰肌醇(GPI)锚定蛋白,表达于小鼠T淋巴细胞表面。我们发现Ly-6A.2(TAP)和Thy-1会被T细胞内化。在本研究中,我们调查了这些GPI锚定蛋白是否通过有被小窝经内吞作用进入细胞。有两条证据表明有被小窝不参与Ly-6A.2(TAP)和Thy-1的内化过程。第一,能有效阻断转铁蛋白受体和H-2 I类分子(已知通过有被小窝内化)内吞作用的药物,并不抑制GPI锚定蛋白的内化。第二,在超微结构分析中,与转铁蛋白受体不同,Ly-6A2(TAP)和Thy-1很少出现在有被小窝或小泡中。这些观察结果表明,T淋巴细胞上的GPI锚定蛋白通过一种不涉及经有被小窝内吞作用的独特途径内化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验